4340 Duncan Avenue St. Louis, MO 63110 314-615-6355 info@biogenerator.org


BioGenerator News

BioGenerator & Cultivation Capital co-lead over-subscribed Series A for tech-enabled services company Healthy Bytes

Nov 27, 2019

ST. LOUIS – St. Louis talent and St. Louis investment have led Healthy Bytes to relocate its headquarters from New York to St. Louis. With investments from Cultivation Capital and […]

Read More

BioGenerator Company Galera Therapeutics Goes Public with $60M IPO

Nov 07, 2019

Galera Therapeutics has raised a $60 million in an initial public offering. The company, which is developing treatments to reduce the harmful effect of radiation therapy, raised the $60 million […]

Read More

Job Opening — Venture Capital Fellows Program

Oct 23, 2019

BioGenerator is seeking qualified candidates to join our team and help us achieve our mission of promoting economic growth and regional prosperity.  BioGenerator, the non-profit investment arm of BioSTL, was […]

Read More

BioGenerator Company Indalo Therapeutics Initiates Dosing in Idiopathic Pulmonary Fibrosis (IPF) Patients

Oct 21, 2019

Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965 October 21, 2019 Key milestone reached in adaptive Phase 1/1b clinical trial that began in April 2019 […]

Read More

BioGenerator Company VaxNewMo Publishes Latest Results in Proceedings of the National Academy of Sciences

Aug 29, 2019

BioGenerator portfolio company noted for its ‘promising technology’ to more quickly and affordably bring vaccines to market ST. LOUIS – St. Louis bioscience startup VaxNewMo is developing broader and more affordable vaccines […]

Read More


Aug 06, 2019

ST. LOUIS, Aug. 6, 2019 – Bayer has awarded BioSTL, a St. Louis-based non-profit which advances and promotes the region’s growing bioscience, innovation and technology community, a $1.5 million grant […]

Read More

BioGenerator company MediBeacon enters into commercialization partnership with Huadong Medicine

Jul 31, 2019

MediBeacon Enters into $30 Million Investment and Exclusive Commercialization Partnership in Greater China with Huadong Medicine MediBeacon and Huadong Medicine will collaboratively work to reach regulatory approval on MediBeacon’s entire […]

Read More

BioGenerator Wins $750,000 Federal Grant to Build New St. Louis Agtech Companies

Jul 24, 2019

Grant expands BioGenerator Labs and Commercialization Resources ST. LOUIS – BioGenerator, the investment arm of BioSTL, has won a $750,000 grant from the U.S. Department of Commerce Economic Development Administration […]

Read More

BioGenerator and Synchrony Bio lead initial financing for Readout, a Digital Health Startup

Jun 13, 2019

Readout adds veteran executive leadership to its management team ST. LOUIS – Readout, an early-stage digital health company, announced completion of its initial funding round, led by BioGenerator, the investment […]

Read More

BioGenerator Company Adarza BioSystems Reaches Commercialization Stage, Launches ZIVA Platform

May 02, 2019

Adarza BioSystems to reveal ZIVA platform at AAI 2019: a fully automated protein multiplex detection system ST. LOUIS (May 2, 2019) — Biotech startup Adarza Biosystems, Inc. announced today that […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors